Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.
Prosperi MC, Cozzi-Lepri A, Castagna A, Mussini C, Murri R, Giacometti A, Torti C, Costantini A, Narciso P, Ghinelli F, Antinori A, d'Arminio Monforte A; Icona Foundation Study Group. Prosperi MC, et al. Among authors: mussini c. Clin Infect Dis. 2010 May 1;50(9):1316-21. doi: 10.1086/651688. Clin Infect Dis. 2010. PMID: 20297953
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B. Mussini C, et al. J Infect Dis. 2000 May;181(5):1635-42. doi: 10.1086/315471. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823763 Clinical Trial.
Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy.
Murri R, Antinori A, Ammassari A, Nappa S, Orofino G, Abrescia N, Mussini C, D'Arminio Monforte A, Wu AW; AdICoNA Study Group. Murri R, et al. Among authors: mussini c. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S158-62. doi: 10.1097/00126334-200212153-00015. J Acquir Immune Defic Syndr. 2002. PMID: 12562042 Review.
Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
Mussini C, Pezzotti P, Antinori A, Borghi V, Monforte Ad, Govoni A, De Luca A, Ammassari A, Mongiardo N, Cerri MC, Bedini A, Beltrami C, Ursitti MA, Bini T, Cossarizza A, Esposito R; Changes in Opportunistic Prophylaxis (CIOP) Study Group. Mussini C, et al. Clin Infect Dis. 2003 Mar 1;36(5):645-51. doi: 10.1086/367659. Epub 2003 Feb 12. Clin Infect Dis. 2003. PMID: 12594647 Clinical Trial.
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study.
Murri R, Lepri AC, Phillips AN, Girardi E, Nasti G, Ferrara S, Mura MS, Mussini C, Petrelli E, Arlotti M, De Stefano C, Vigano P, Novati R, Cargnel A, Monforte AD; I.Co.N.A. Study Group. Murri R, et al. Among authors: mussini c. J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):184-90. doi: 10.1097/00126334-200310010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 14526207
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Mussini C, Pezzotti P, Miró JM, Martinez E, de Quiros JC, Cinque P, Borghi V, Bedini A, Domingo P, Cahn P, Bossi P, de Luca A, d'Arminio Monforte A, Nelson M, Nwokolo N, Helou S, Negroni R, Jacchetti G, Antinori S, Lazzarin A, Cossarizza A, Esposito R, Antinori A, Aberg JA; International Working Group on Cryptococcosis. Mussini C, et al. Clin Infect Dis. 2004 Feb 15;38(4):565-71. doi: 10.1086/381261. Epub 2004 Jan 29. Clin Infect Dis. 2004. PMID: 14765351 Free article.
Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection.
Cossarizza A, Poccia F, Agrati C, D'Offizi G, Bugarini R, Pinti M, Borghi V, Mussini C, Esposito R, Ippolito G, Narciso P. Cossarizza A, et al. Among authors: mussini c. J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):213-22. doi: 10.1097/00126334-200403010-00001. J Acquir Immune Defic Syndr. 2004. PMID: 15076235 Clinical Trial.
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration. Ledergerber B, et al. Among authors: mussini c. Lancet. 2004 Jul 3-9;364(9428):51-62. doi: 10.1016/S0140-6736(04)16589-6. Lancet. 2004. PMID: 15234856
773 results